The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bayer
Speakers' Bureau - Intramed
Regorafenib in previously treated metastatic colorectal cancer (mCRC): Analysis of age subgroups in the open-label phase IIIb CONSIGN trial.
 
Eric Van Cutsem
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
 
Fortunato Ciardiello
Consulting or Advisory Role - AstraZeneca; Bayer; Lilly; Merck Serono; Roche; Sanofi
Research Funding - AstraZeneca; Bayer; Merck Serono; Roche
 
Marc Ychou
Honoraria - Bayer; Merck; Roche
Consulting or Advisory Role - Bayer; Merck; Roche
 
Jean Francois Seitz
Honoraria - Amgen; Bayer; Merck Serono
Consulting or Advisory Role - Roche; Sanofi
 
Ralf Hofheinz
Honoraria - Amgen; Bayer; Medac; Merck; Roche; Sanofi
Research Funding - Amgen; Medac; Merck; Roche; Sanofi
 
Yull Edwin Arriaga
No Relationships to Disclose
 
Udit Verma
No Relationships to Disclose
 
Rocio Garcia-Carbonero
Honoraria - Amgen (I); Boehringer Ingelheim (I); Lilly (I); Merck (I); Novartis (I); Pfizer (I); Roche (I)
Consulting or Advisory Role - Boehringer Ingelheim (I); Lilly (I); Pfizer (I); Roche (I)
Research Funding - IPSEN
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim (I); Ipsen; Lilly (I); Merck; Novartis; Pfizer; Pfizer (I); Roche; Roche (I); Sanofi
 
Axel Grothey
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Sanofi (Inst)
Research Funding - Bayer (Inst); Boston Biomedical (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche
 
Ashok Miriyala
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Joachim Kalmus
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Christian Kappeler
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Alfredo Falcone
Honoraria - Amgen; Bayer; Lilly; Merck; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; Bayer; Lilly; Merck; Roche; Sanofi; SERVIER
Research Funding - Amgen; Bayer; Merck; Roche; Sanofi
 
Alberto Zaniboni
No Relationships to Disclose